Novel anti-cancer treatments use knowledge about the underlying biology of the tumor to find suitable molecular targets. The recent years have seen great advances in understanding the biology of melanoma. In the current review we discuss the most promising molecular targets for melanoma and suggest possible strategies for overcoming resistance.
No takes yet. Share an insight, caveat, or question.
Smalley et al. (2006) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: